Kuros Biosciences AG
Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company offers MagnetOs Granules, an original advanced bone graft based on the submicron needle-shaped NeedleGrip surface technol… Read more
Kuros Biosciences AG - Asset Resilience Ratio
Kuros Biosciences AG (CSBTF) has an Asset Resilience Ratio of 0.00% as of December 2018. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2005–2023)
This chart shows how Kuros Biosciences AG's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Kuros Biosciences AG's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: Kuros Biosciences AG maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
Kuros Biosciences AG Industry Peers by Asset Resilience Ratio
Compare Kuros Biosciences AG's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022 |
Medical Devices | 0.01% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.26% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 7.79% |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932 |
Medical Devices | 6.64% |
|
Shinhung
KO:004080 |
Medical Devices | 4.17% |
|
UMediC Group Berhad
KLSE:0256 |
Medical Devices | 1.48% |
|
Osang Healthcare Co.,Ltd
KQ:036220 |
Medical Devices | 9.34% |
|
HansBiomed Corporation
KQ:042520 |
Medical Devices | 9.13% |
Annual Asset Resilience Ratio for Kuros Biosciences AG (2005–2023)
The table below shows the annual Asset Resilience Ratio data for Kuros Biosciences AG.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 0.48% | $342.00K | $71.46 Million | -- |
| 2018-12-31 | 0.00% | $0.00 | $85.82 Million | -- |
| 2017-12-31 | 0.00% | $0.00 | $86.08 Million | -- |
| 2016-12-31 | 0.00% | $0.00 | $43.77 Million | -- |
| 2015-12-31 | 1.99% | $65.00K | $3.26 Million | -10.99pp |
| 2011-12-31 | 12.98% | $4.00 Million | $30.81 Million | -1.81pp |
| 2010-12-31 | 14.80% | $8.00 Million | $54.07 Million | -39.06pp |
| 2009-12-31 | 53.86% | $37.00 Million | $68.70 Million | +16.84pp |
| 2008-12-31 | 37.02% | $41.00 Million | $110.75 Million | -16.40pp |
| 2007-12-31 | 53.42% | $66.00 Million | $123.56 Million | +22.06pp |
| 2006-12-31 | 31.35% | $18.00 Million | $57.41 Million | +30.89pp |
| 2005-12-31 | 0.46% | $379.00K | $82.39 Million | -- |